Xcout IntelOptimi Health Corp. competitors & alternatives
The 12 closest competitors and alternatives to Optimi Health Corp. among biotech companies — ranked by similarity to what Optimi Health Corp. actually does, not by market-cap band.
Subscribe to see Optimi Health Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Optimi Health Corp.
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
Optimi Health Corp. at a glance
Optimi Health Corp. is a biotech company headquartered in Princeton, Canada. It is publicly listed (OPTH) with a market capitalisation of $23.8M. Xcout tracks 16 named people at Optimi Health Corp., including Bryan Safarik (Chief Operating Officer).
Optimi Health Corp. leadership
- Bryan SafarikChief Operating Officer
- Jacob SafarikInterim CFO & Director
- Dr. Preston ChaseChief Science Officer
- Michael BloughChief Clinical Development Officer
- Preston A. ChaseChief Science Officer
- Robert MartinChief Strategy Officer
10 more named people on record for Optimi Health Corp., with roles, board committees and tenure — see the full roster →
Recent Optimi Health Corp. news
- IPOIPO registration (F-1)
- IPOIPO registration (F-1)
- IPOIPO registration (F-1)
- IPOIPO registration (F-1)
5 corporate events on record, with sources — see the full timeline →
Top 12 Optimi Health Corp. competitors
Ranked by semantic similarity — how close each company is to Optimi Health Corp. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Similar biotech company
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Similar biotech company
BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Similar biotech company
Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.
Biotechnology
Bloom Labs Bio Inc. specializes in the development and manufacturing of biologics, biosimilars, recombinant proteins, monoclonal antibodies, prebiotics, and probiotics. Utilizing modern biotechnology platforms and advanced infrastructure, the company serves the pharmaceutical and life sciences sectors with therapeutic and health and wellness solutions.
Similar biotech company
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Biotechnology
Probi researches, develops, and manufactures science-backed probiotic and biotic solutions for businesses operating in the dietary supplement, food and beverage, and pet care industries. The company provides customized probiotic strains, raw materials, and finished product manufacturing targeting various health areas such as digestive, immune, metabolic, and mental health.
Similar biotech company
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.
Biotechnology
Emerald Health Bioceuticals Inc. develops biology-based life science solutions focused on enhancing human, animal, and plant life. The company utilizes advanced research, fermentation, biomanufacturing, and process development to create safe and sustainable products for its partners and customers.
Biotechnology
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
Biotechnology
Outlier BioPharma Inc. is a vertically integrated biotechnology company that provides cultivation, extraction, research and development, and global distribution services for cannabis and cannabinoid-based products. The company serves partners in the cannabis industry by offering turn-key contract processing, private-label manufacturing, genetics development, and wholesale distribution.
Life Sciences
PharmaTher Holdings Ltd. is a life sciences company focused on the development of personalized medicines, including peptides and psychedelics such as ketamine and cepharanthine. The company also utilizes pharmaceutical 3D printing technology for personalized medicine applications.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Optimi Health Corp. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Optimi Health Corp.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →